CN100386111C - 肝胆胃复康合剂及其制备方法 - Google Patents
肝胆胃复康合剂及其制备方法 Download PDFInfo
- Publication number
- CN100386111C CN100386111C CNB2004100602958A CN200410060295A CN100386111C CN 100386111 C CN100386111 C CN 100386111C CN B2004100602958 A CNB2004100602958 A CN B2004100602958A CN 200410060295 A CN200410060295 A CN 200410060295A CN 100386111 C CN100386111 C CN 100386111C
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- liver
- mixture
- stomach
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004185 liver Anatomy 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 210000002784 stomach Anatomy 0.000 title abstract description 17
- 210000000232 gallbladder Anatomy 0.000 title abstract description 14
- 238000000034 method Methods 0.000 title abstract description 3
- 238000011084 recovery Methods 0.000 title abstract 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000000605 extraction Methods 0.000 claims abstract description 5
- 238000011010 flushing procedure Methods 0.000 claims abstract description 4
- 239000012535 impurity Substances 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 36
- 241000283956 Manis Species 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 7
- IVQOFBKHQCTVQV-UHFFFAOYSA-N 2-hydroxy-2,2-diphenylacetic acid 2-(diethylamino)ethyl ester Chemical compound C=1C=CC=CC=1C(O)(C(=O)OCCN(CC)CC)C1=CC=CC=C1 IVQOFBKHQCTVQV-UHFFFAOYSA-N 0.000 claims description 5
- 229960001498 benactyzine Drugs 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 238000013467 fragmentation Methods 0.000 claims description 3
- 238000006062 fragmentation reaction Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims 1
- 206010023126 Jaundice Diseases 0.000 abstract description 13
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 244000025254 Cannabis sativa Species 0.000 abstract description 9
- 230000006870 function Effects 0.000 abstract description 6
- 235000013399 edible fruits Nutrition 0.000 abstract description 4
- 239000007788 liquid Substances 0.000 abstract description 3
- 230000001914 calming effect Effects 0.000 abstract description 2
- 239000003053 toxin Substances 0.000 abstract description 2
- 231100000765 toxin Toxicity 0.000 abstract description 2
- 241001127714 Amomum Species 0.000 abstract 2
- 235000008658 Artemisia capillaris Nutrition 0.000 abstract 2
- 241000092668 Artemisia capillaris Species 0.000 abstract 2
- 241000675108 Citrus tangerina Species 0.000 abstract 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 2
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 2
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 2
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 2
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 2
- 240000000171 Crataegus monogyna Species 0.000 abstract 2
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 2
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 2
- 241001598107 Imperata Species 0.000 abstract 2
- 241000219991 Lythraceae Species 0.000 abstract 2
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 2
- 240000008790 Musa x paradisiaca Species 0.000 abstract 2
- 241000283966 Pholidota <mammal> Species 0.000 abstract 2
- 235000015266 Plantago major Nutrition 0.000 abstract 2
- NEZONWMXZKDMKF-SNVBAGLBSA-N Shikonin Chemical compound C1=CC(O)=C2C(=O)C([C@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-SNVBAGLBSA-N 0.000 abstract 2
- 240000001949 Taraxacum officinale Species 0.000 abstract 2
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 2
- 244000137773 Viola philippica Species 0.000 abstract 2
- 244000273928 Zingiber officinale Species 0.000 abstract 2
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 2
- 229940126678 chinese medicines Drugs 0.000 abstract 2
- 235000008397 ginger Nutrition 0.000 abstract 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract 2
- 241000411851 herbal medicine Species 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 15
- 239000000796 flavoring agent Substances 0.000 description 15
- 235000019634 flavors Nutrition 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 206010012735 Diarrhoea Diseases 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 208000007882 Gastritis Diseases 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 201000001352 cholecystitis Diseases 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- -1 give birth to Mao Su Chemical compound 0.000 description 5
- 230000004206 stomach function Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- GUAFOGOEJLSQBT-UHFFFAOYSA-N scoparone Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(OC)=C2 GUAFOGOEJLSQBT-UHFFFAOYSA-N 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 208000000913 Kidney Calculi Diseases 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 3
- 206010067171 Regurgitation Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 208000001130 gallstones Diseases 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- GSFDOOHGKOHDEL-UHFFFAOYSA-N Dalpanitin Natural products COc1cc(ccc1O)C2=COc3c(C4OC(CO)C(O)C(O)C4O)c(O)cc(O)c3C2=O GSFDOOHGKOHDEL-UHFFFAOYSA-N 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 208000004356 Hysteria Diseases 0.000 description 2
- 206010029148 Nephrolithiasis Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 201000001883 cholelithiasis Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000023652 chronic gastritis Diseases 0.000 description 2
- 206010009887 colitis Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 208000012839 conversion disease Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 229960000282 metronidazole Drugs 0.000 description 2
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 2
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- SVHDRHWULLNMQC-UHFFFAOYSA-N scoparone Natural products C1=CC(=O)OC2=C1C=C(C(=O)C)C(C(C)=O)=C2 SVHDRHWULLNMQC-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000000197 Acute Cholecystitis Diseases 0.000 description 1
- 206010059193 Acute hepatitis B Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- MRNPHCMRIQYRFU-KXUMSINMSA-N Arundoin Chemical compound C([C@]1(C)[C@@H](C(C)C)CC[C@H]1[C@]1(C)CC=C23)C[C@]1(C)[C@H]3CC[C@@H]1[C@]2(C)CC[C@H](OC)C1(C)C MRNPHCMRIQYRFU-KXUMSINMSA-N 0.000 description 1
- NWUMSRKLBRWRAS-UHFFFAOYSA-N Arundoin Natural products COC1CCC2(C)C(CCC3C2=CCC4(C)C5CC(C)(C)CCC5(C)CCC34C)C1(C)C NWUMSRKLBRWRAS-UHFFFAOYSA-N 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000269417 Bufo Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 206010008614 Cholecystitis acute Diseases 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 241000480045 Citrus suavissima Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 244000293323 Cosmos caudatus Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000508725 Elymus repens Species 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 241000371997 Eriocheir sinensis Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 241000123871 Gueldenstaedtia verna Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 241000594394 Hedyotis Species 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010056972 Hydrocholecystis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- FDQAOULAVFHKBX-UHFFFAOYSA-N Isosilybin A Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC(=CC=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 FDQAOULAVFHKBX-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241001571764 Lysimachia christinae Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001347978 Major minor Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- OBIOZWXPDBWYHB-UHFFFAOYSA-N Nobiletin Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 OBIOZWXPDBWYHB-UHFFFAOYSA-N 0.000 description 1
- 206010058117 Ocular icterus Diseases 0.000 description 1
- 241001093219 Osyris Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 239000008923 Qingkailing Substances 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- VLGROHBNWZUINI-UHFFFAOYSA-N Silybin Natural products COc1cc(ccc1O)C2OC3C=C(C=CC3OC2CO)C4Oc5cc(O)cc(O)c5C(=O)C4O VLGROHBNWZUINI-UHFFFAOYSA-N 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- HJLSLZFTEKNLFI-UHFFFAOYSA-N Tinidazole Chemical compound CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O HJLSLZFTEKNLFI-UHFFFAOYSA-N 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 241000543657 Triglochin Species 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000037628 acute hepatitis B virus infection Diseases 0.000 description 1
- 208000017515 adrenocortical insufficiency Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical group CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- 235000008718 isoliquiritigenin Nutrition 0.000 description 1
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 229940043175 silybin Drugs 0.000 description 1
- 235000014899 silybin Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960005053 tinidazole Drugs 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 238000009603 uroscopy Methods 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于中药制成的中草药合剂。提出的肝胆胃复康合剂是由下述用量为重量份的组分制成:黄花茵陈25~30、金钱草3~5、白茯苓3~5、车前草10~15、穿山甲2~3、阳春砂仁0.6~1,东楂6~10、青皮6~10、生姜1.5~2、大枣1~1.5、甘草3~5、蒲公英15~30、紫花地丁15~30、白茅根15~30。本发明的制备方法为:先取黄花茵陈、金钱草、蒲公英、紫花地丁、白茅根、车前草用清水冲洗,然后快速取出去掉杂质,再将白茯苓、穿山甲、阳春砂仁破碎和东楂、青皮、甘草、大枣、生姜一起放入中药提取浓缩,然后加入1∶3的水,再提取浓缩即制得本合剂。本发明使药液入胃快速,直达病处,具有清肝、利胆、退黄、和胃败毒之功效。
Description
所属技术领域
本发明属于中药制成的中草药合剂,主要是涉及一种肝胆胃复康合剂及其制备方法。
背景技术
目前,国内外治疗急慢性黄疸、无黄疸型肝炎,乙型肝炎,胆囊炎,胆肾结石,胃炎,结肠炎(便秘或腹泻),乳腺小叶增生,盆腔炎,多囊肝多囊肾的治疗药物甚多,如肝太乐、强力宁针、斯达舒、多酶片,氨卞青霉针、肾石通、消石素、维生素C片、甲硝唑、替硝唑等的胶囊、片剂或针剂,由于胶囊均在胃崩解,且吸收缓慢,还存在刺激性较大或毒性较强的缺陷,影响治疗效果。通过输液对身体损伤较大,且吸收较少,使其治疗效果不理想。单味药物均达不到君、臣、佐、使之功效,对疾病的攻势不强,见效不直接,影响药力发挥,导致疗效不佳。
发明内容
本发明的目的在于,提出一种肝胆胃复康合剂及其制备方法,使药液入胃快速,直达病处,具有清肝、利胆、退黄、和胃败毒之功效。
本发明药物是由下述用量为重量份的组分制成:黄花茵陈25~30、金钱草3~5、白茯苓3~5、车前草10~15、穿山甲2~3、阳春砂仁0.6~1,东楂6~10、青皮6~10、生姜1.5~2、大枣1~1.5、甘草3~5、蒲公英15~30、紫花地丁15~30、白茅根15~30。
将上述各组分制成本发明药物的生产方法是:先取黄花茵陈、金钱草、蒲公英、紫花地丁、白茅根、车前草用清水冲洗,然后快速取出去掉杂质,再将白茯苓、穿山甲、阳春砂仁破碎和东楂、青皮、甘草、大枣、生姜一起放入中药提取浓缩,然后加入1∶3的水,再提取浓缩即制得本合剂。
本发明组分中:
黄花茵陈,异名:“茵陈”“茵陈蒿”,性味:苦、平、微寒,无毒,内含蒿属香豆素,绿原酸、脂肪油、挥发油等,具有清热利湿、利胆、退黄之功,治疗湿热黄疸、胆囊炎、伤署发热、小便不利、风瘙瘾疹、湿疮。
金钱草,异名:“大金钱草”、“过路黄”,性味,淡、微寒。具有清热利胆、排石,利尿消肿,治疗湿热黄疸、胆道结石、尿路结石、感染、外科恶疮肿毒。
紫花地丁,异名:“米口袋”“地丁草”“箭头草”,性味:苦、寒,内含有甙类、黄酮类,具有清热解毒、消肿之功,治疗疔疮、痈肿、丹毒、瘰疬、毒蛇咬伤、目赤肿痛、咽炎、黄疸型肝炎、肠炎、痢疾。
蒲公英,异名:“黄花地丁”“婆婆丁”“奶汁草”“黄花三七”,性味:苦、甘、寒,内含蒲公英甾醇、胆碱、蒲公英素、蒲公英苦素、菊糖和果胶,具有清热解毒、消痛散结,治疗上呼吸道感染、扁桃体炎、咽喉炎、流行性腮腺炎、眼结膜炎、淋巴结炎、肺炎、急性胆囊炎、胰腺炎、肝炎、胃炎、肠炎、痢疾、急性乳腺炎、阑尾炎、尿路感染、盆腔炎、疔疮疖肿。
白茅根,异名“茅根”“地营”“地节根”“茅草根”“丝毛草根”,性味:甘、寒,内含多量庶糖、葡萄糖、钾盐、钙、少量草酸、柠檬酸、生茅素、芦竹素,具有清热凉血、止血、利尿,治疗热病烦渴、胃热呕吐、肺热咳嗽、吐血、衄血、咳血、尿血、急性肾炎、水肿、黄疸。
白茯苓异名“茯菟”“白茯苓”,性味:甘、淡、平,内含有茯苓酸、乙酰茯苓酸、齿乳酸、去氢齿乳酸、松苓酸等三萜成分和β-茯苓聚糖、麦角甾醇、卵磷酯等,具有利水渗湿、健脾和胃、宁心安神之功,治疗小便不利,水肿胀满,痰饮咳嗽,食少脘闷、大便泄泻,心悸、失眠。
车前草,异名:“蟾蜍草”“牛舌草”“田菠草”“打官司草”“虾蝧草”“车轮草”“猪耳草”,性味甘、寒,内含车前甙、熊果酸、β-谷甾醇,具有清热利尿,明目降压,祛痰止咳,治疗小便不利、淋浊带下、尿血、黄疸、水肿、热痢泄泻,目赤肿痛、高血压病、气管炎、百日咳等。
穿山甲,异名“鲮鲤甲”“川山甲”,性味:咸,微寒,内含硬脂酸、胆甾醇,挥发油、水洛性生物碱、微量元素、氨基酸、无机物等,具有活血通络、下乳、消肿、排脓之功,治疗经闭乳汁不下、症瘕、风痹强直疼痛、筋骨拘挛、痈肿初起或脓成不溃。
砂仁,异名:“春砂仁”“缩沙密”“缩壳砂”,性味:辛、温;内含有挥发油、樟脑、龙脑、乙酸龙脑酯、柠檬烯、皂甙等,具有化湿开胃、温中止泻,理气安胎之功。治疗湿浊中阻、脘痞不饥、脾胃虚寒、呕吐泄泻,妊娠恶阻,胎动不安。
东楂,异名:“红果”“山里果”“牧虎梨”,性味:酸、甘、微温,内含有柠檬酸、苹果酸、维生素C、鞣质、生物懈皮素等,具有消食化积、散瘀,治疗肉积食滞、腹痛泄泻、细菌性痢疾、痰饮痞满吞酸、黄疸、疝气偏坠胀痛,痛经、辛后恶露不尽、瘀滞痛、小儿疳积,现代用于治疗高血脂症。
青皮,异名:“小青皮”“青桔皮”“青柑皮”,性味:苦、辛、温,内含有挥发油、黄酮甙、川皮酮、维生素B、维生素C等,具有疏肝理气,散结化滞之功,治疗肝气郁结,胸胁疼痛、疝气痛、乳胀、乳房结块、胃脘胀痛、消化不良、食积痞满,久疟结癖。
生姜,性味辛、温,内含挥发油,主要成份为姜醇、姜稀、水芹烯、莰烯、龙脑等,所含辣味成分为姜辣素,具有发表散寒、消痰下气、温中止呕,治疗感冒风寒、呕吐痰饮、咳喘、胀满泄泻、解半夏、天南星及鱼蟹禽兽肉毒。
大枣,异名“红枣”“干果”“姜枣”“良枣”,性味:甘、温,内含蛋白质、糖类,多种氨基酸、胡萝卜素、维生素A、维生素B2、维生素C、微量元素,钙、磷、镁等化合物,具有补中益气、养血安神之功,治疗脾胃虚弱、食少便、倦怠乏力、气血不足、心悸怔忡、过敏性紫癜、妇人脏躁,并能缓和峻烈药物的毒性,减少副作用。
甘草,异名“姜草”“密草”“国老”“粉草”,性味:甘、平,内含主要系甘草酸的钾、钙盐,还含有24~羟基甘草次酸等三萜类及甘草素、异甘草素、甘草甙、异甘草甙、新甘草甙等黄酮类,并含苦味质、树脂等,具有补脾和胃、缓急止痛、祛痰止咳、解毒、调和诸药,治疗脘腹挛痛、咳嗽、心悸、癔病、咽喉肿痛、疮疡肿毒、药物及食物中毒,用于治疗肾上腺皮质功能减退症。
由上述药物组成的肝胆胃合剂,为棕褐色液体,其气味芳香,味酸、甜、微苦,口感适宜。所选的药材系天然中草药物,药材地道,遵古炮制,采用现代先进工艺配制而成。经过多年临床应用证明,本发明具有清肝、胆、退黄、和胃败毒之功,主要用于治疗急慢性无黄疸型、黄疸型肝炎,急慢性乙肝,胆囊炎,胆肾结石,结肠炎(便秘或腹泻),乳腺小叶增生,急慢利性胃炎,盆腔炎,多囊肝多囊肾等。
本发明在组方中引用了中医“君、臣、佐、使”加以配方,实际为现代组方的主、辅、协、调配方原则,即针对复杂多变的病症,将多数药物有系统分主次地配伍起来,组成一个合理的配方,以发挥起应有的功效。主药(君药)起主导作用,解决疾病主要矛盾的药,在一个处方中可以是一味或一味以上。辅助药(臣药)是配合主药和加强主药作用的药物,在一个处方中可以为一味或一味以上。协制药(佐药)有二层意思,一是协助主药解决疾病次要矛盾,二是制约主药的副作用,通常在一个处方里有两味以上。调和药(使药)是在药方中调和诸药,纠正其偏性和毒性,还有引经的作用,可引诸药直达病所,所以又称引经药。
本发明组方中,茵陈内含独有的蒿属香豆素,清肝、胆、胃肠之热,以利胆、退黄为主药,方中起主导作用。金钱草、车前草、紫花地丁、砂仁、蒲公英内含有甙、素类,败毒、清热利下焦协助主药发挥次要作用和加强主药作用。茯苓、白茅根、穿山甲、东楂、青皮、大枣、生姜内含酸酮烯等缓和主辅药的太过和不及,和胃调肝、散瘀通络、进食强身为协药。甘草内含甙、素、次酸苦味质、树酯、钾、钙、盐、酮类具有调和诸药,解百药之毒性,又能引诸药直达病所。
典型病例:
1、柴长海,男,46岁,白沙乡,长寿寨村22组村民。于2000年10月13日初诊,患肝炎病60天。主诉:腹胀、纳呆、小便黄,乏力二个月,曾多次到当地医院治疗,服用肝太乐、维生素C片、益肝灵、多酶片,静脉注射清开灵、强力宁针等,交替应用40天,疗效欠佳。前来求治,症状:胸胁胀满、撑疼、食欲不振、口苦恶心,肢倦乏力,小便色黄,大便不调,面色欠华,肤色不泽,目黄、舌苔黄稍厚、脉细而弦。经二维彩色多普勒声像仪检查提示:肝实质回声增粗、增强,光点密焦,胆囊炎,胆囊大小96.4×25.9×24.4mm,壁厚5.3mm,壁增厚毛糙,胆汁透声性差。肝功检查提示:ALT:146.9u/c,TBIC:42.2umol/L,D-BIL:27.2umol/L,IBIL<15.4umol/L,五项指标提示:HBSAg(+),抗-HBSAb(-),HBeAb(+),抗-HBeAb(-),抗-HBcAb(+)。尿检查:尿三胆阳性。根据以上检查结果和症状表现,属肝胆湿热;诊断为:急性乙型黄疸性肝炎,胆囊炎。治宜:清肝、利胆、退黄、败毒。选用本发明的肝胆胃合剂250ml,每次80ml,每天三次,分早、中、晚温口服20天。
于2000年11月3日二诊:症状全消,面色转华,食欲大增,大小便正常,病人高兴而来,继续服用肝胆胃合剂15天,每天三次,每次80ml,仍早中晚口服。
于2000年11月18日三诊:患者服用肝胆胃合剂45天,复查肝功:转氨酶46u/L,黄疸消失。五项指标大三阳转小三阳。复查二维彩色多普勒声像仪检查:肝脏回声均匀,光点细密。胆囊水肿消失,尿三胆呈阴性。症状全消,食欲大增,寻问病人:无任何不适。为了患者的疗效巩固和抗病毒治疗嘱病人服用肝胆胃合剂加强半年,2002年6月17日患者带自己母亲前来看胃病,随访病人情况:服完半年肝胆胃合剂后,经县、市、省、三级医院肝功检查:肝功正常。五项指标均全部转阴。二维彩色多普勒声像仪检查:肝、胆、脾、肤均未见异常。后又追访一年余未复发。
2、王朝,男,70岁,江左乡,乔沟村老支部书记。患慢性胃炎、胃疼病有26年,时常胃脘闷胀反酸,暧气,撑顶疼痛难忍,曾多次到医院求专家诊治,都是慢性胃炎,服用斯达舒、甲硝唑、西沙比列、雷尼替丁、阿膜西林、复方胃友、胃得乐,静脉注射氨苄青霉素、甲青咪呱针,交替应用多年,疗效欠佳。虽着年龄增大,病情进展,症状加重,患者痛苦至极,慕名前来求治;观患者:胃脘闷胀,撑顶疼痛,饱则刺痛,饥之则稳痛时常不断,呃逆,反酸,大便时溏时泻,形体消瘦,肤色淡黄无华,进食极少,时有恶心,呕吐,痛苦病容,口干、舌苔黄腻较厚,脉沉滑。二维采色多普勒声像仪检查提示:肝胆脾胰未见异常。胃镜检查:1、慢性充血水肿性胃炎;2、重度靡烂性胃炎(大胃大弯、幽门管处多处糜烂)。3、十二指肠球部溃疡;证属:湿热蕴结,肝胃失和。治宜:和胃败毒。选用本发明的肝胆胃合剂250ml,一日三次,一次80ml,口服六天,另加服珍珠白芨散,每天三次,每次2g,饭前开水服。
二诊于2002年10月9日,服药6天,症状减轻,进食增加,病人高兴前来,继续服药10天。
三诊于2002年10月19日,服药16天后,症状全消,进食香,身体有力,腹软无压痛,再服药10天,病者共服药26天,复查胃镜提示:十二指肠球部
溃疡缩至3/4大小,胃充血水肿糜烂均恢复正常。然后再服用20天,以巩固疗效,半年后随访患者精神良好,体力恢复,可参加轻体力劳动,未有任何不适。
具体实施方式
实施例1
本发明药物由下述用量为重量份的组分构成:
黄花茵陈25、金钱草3、白茯苓3、车前草10、穿山甲2、阳春砂仁0.6,东楂6、青皮6、生姜1.5、大枣1、甘草3、蒲公英15、紫花地丁15、白茅根15。
本实施例的制备方法是:先取黄花茵陈、金钱草、蒲公英、紫花地丁、白茅根车前草用清水冲洗,然后快速取出去掉杂质,再将白茯苓、穿山甲、阳春砂仁破碎和东楂、青皮、甘草、大枣、生姜一起放入中药提取浓缩,然后加入1∶3的水,再提取浓缩即制得本合剂。
实施例2
本发明药物由下述用量为重量份的组分构成:
黄花茵陈28、金钱草4、白茯苓4、车前草13、穿山甲2.5、阳春砂仁0.8,东楂8、青皮8、生姜1.8、大枣1.3、甘草4、蒲公英28、紫花地丁23、白茅根23。
本实施例的制备方法同实施例1。
实施例3
本发明药物由下述用量为重量份的组分构成:
黄花茵陈30、金钱草5、白茯苓5、车前草15、穿山甲3、阳春砂仁1,东楂10、青皮10、生姜2、大枣1.5、甘草5、蒲公英30、紫花地丁30、白茅根30。
本实施例的制备方法同实施例1。
Claims (2)
1.一种肝胆胃复康合剂,其特征在于:本发明药物是由下述用量为重量份的原料制成:黄花茵陈25~30、金钱草3~5、白茯苓3~5、车前草10~15、穿山甲2~3、阳春砂仁0.6~1,东楂6~10、青皮6~10、生姜1.5~2、大枣1~1.5、甘草3~5、蒲公英15~30、紫花地丁15~30、白茅根15~30。
2.根据权利要求1所述肝胆胃复康合剂的制备方法,其特征在于:先取黄花茵陈、金钱草、蒲公英、紫花地丁、白茅根、车前草用清水冲洗,然后快速取出去掉杂质,再将白茯苓、穿山甲、阳春砂仁破碎和东楂、青皮、甘草、大枣、生姜一起放入中药提取浓缩,然后加入1∶3的水,再提取浓缩即制得本合剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100602958A CN100386111C (zh) | 2004-11-30 | 2004-11-30 | 肝胆胃复康合剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100602958A CN100386111C (zh) | 2004-11-30 | 2004-11-30 | 肝胆胃复康合剂及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1781546A CN1781546A (zh) | 2006-06-07 |
| CN100386111C true CN100386111C (zh) | 2008-05-07 |
Family
ID=36772417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100602958A Expired - Fee Related CN100386111C (zh) | 2004-11-30 | 2004-11-30 | 肝胆胃复康合剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100386111C (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101507496B (zh) * | 2009-03-11 | 2014-04-09 | 刘勇华 | 苦瓜藤健胃饮品的加工方法 |
| CN103120732B (zh) * | 2011-11-18 | 2015-01-14 | 北京亚东生物制药有限公司 | 一种治疗黄疸的中药组合物及其制备方法 |
| CN103431426A (zh) * | 2013-07-25 | 2013-12-11 | 柳培健 | 一种海带排骨罐头的生产方法 |
| CN103550740B (zh) * | 2013-11-01 | 2015-06-10 | 杨献华 | 一种治疗黄疸型肝炎的中药组合物及其应用 |
| CN104740558A (zh) * | 2014-10-31 | 2015-07-01 | 合肥平光制药有限公司 | 一种治疗胆结石合并胆囊炎的中药组合物 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1207314A (zh) * | 1998-04-28 | 1999-02-10 | 叶坦 | 一种治疗乙肝的中药 |
| CN1380098A (zh) * | 2002-05-20 | 2002-11-20 | 张勇飞 | 一种抗感染复合制剂及其制备方法 |
-
2004
- 2004-11-30 CN CNB2004100602958A patent/CN100386111C/zh not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1207314A (zh) * | 1998-04-28 | 1999-02-10 | 叶坦 | 一种治疗乙肝的中药 |
| CN1380098A (zh) * | 2002-05-20 | 2002-11-20 | 张勇飞 | 一种抗感染复合制剂及其制备方法 |
Non-Patent Citations (4)
| Title |
|---|
| 肝胆疾病的辩证论治和用药. 杜昆.首都医药,第7卷第6期. 2000 |
| 肝胆疾病的辩证论治和用药. 杜昆.首都医药,第7卷第6期. 2000 * |
| 胆系疾病的中医药研究. 匡奕璜等.江西中医药,第28卷第5期. 1997 |
| 胆系疾病的中医药研究. 匡奕璜等.江西中医药,第28卷第5期. 1997 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1781546A (zh) | 2006-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102068707B (zh) | 一种b超使用的中药助影剂及其制备方法 | |
| CN100404067C (zh) | 治疗儿童肺系疾病的中药制剂 | |
| CN101085328A (zh) | 一种内服治疗慢性胃炎的中药组合物 | |
| CN103989970B (zh) | 一种治疗高血压的中药组合物 | |
| CN100386111C (zh) | 肝胆胃复康合剂及其制备方法 | |
| CN104940718A (zh) | 一种治疗慢性胆囊炎的药物组合物及其制备方法 | |
| CN103536690B (zh) | 一种降血压的中药口服液 | |
| CN107213360A (zh) | 一种治疗重型肌无力的中药组合物 | |
| CN104758701A (zh) | 一种胃结石碎石后护理治疗的药物及其制备方法 | |
| CN103251871B (zh) | 治疗胃下垂的中药汤剂 | |
| CN102631481B (zh) | 一种治疗病毒性肝炎的中药制剂 | |
| CN109700995B (zh) | 一种治疗消化性溃疡的药物组合物及其制备方法 | |
| CN108686197A (zh) | 一种治疗胃炎的中药组合物及其应用 | |
| CN107854662A (zh) | 一种治疗肝硬化腹水的中药制剂及其制备方法 | |
| CN101129526A (zh) | 一种治疗糖尿病的中药 | |
| CN104940777A (zh) | 一种治疗肝旺脾弱型经行泄泻的冲剂及其制备方法 | |
| CN106668696A (zh) | 一种治疗原发性胆汁性肝硬化的中药制剂 | |
| CN105920539A (zh) | 一种治疗羊口蹄疫的药物 | |
| CN105288166A (zh) | 一种用于甲状腺肿大的中药组合物及其制备方法 | |
| CN105727148A (zh) | 一种治疗肝硬化腹水的药物及其制备 | |
| CN105031335A (zh) | 一种胃结石微波碎石后护理治疗的药物及其制备方法 | |
| CN105106691A (zh) | 一种用于治疗口臭的中药汤剂 | |
| CN104435900A (zh) | 治疗风湿性关节炎的药物及制法 | |
| CN114306559A (zh) | 一种内服外洗治疗痛风性关节炎的配方 | |
| CN103977213A (zh) | 用于治疗脾胃虚寒型慢性胃炎的保健药品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |